Amrize Ltd (AMRZ) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Amrize Ltd (AMRZ) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Amrize Ltd (AMRZ) reported $3.49 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 8.5%. EPS of $0.88 for the same period compares to $0.78 a year ago.
The reported revenue represents a surprise of +3.73% over the Zacks Consensus Estimate of $3.37 billion. With the consensus EPS estimate being $0.92, the EPS surprise was -4.35%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Amrize Ltd performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Building Envelope: $1.05 billion compared to the $941.44 million average estimate based on three analysts.
- Revenues- Building Materials: $2.45 billion versus $2.43 billion estimated by three analysts on average.
- Adjusted EBITDA- Building Materials: $793 million versus the three-analyst average estimate of $833.15 million.
- Adjusted EBITDA- Building Envelope: $237 million versus $226.8 million estimated by three analysts on average.
- Adjusted EBITDA- Unallocated corporate costs: $-44 million versus $-50 million estimated by two analysts on average.
View all Key Company Metrics for Amrize Ltd here>>>
Shares of Amrize Ltd have returned +6.9% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amrize Ltd (AMRZ): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).